Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | POLYMER SCIENCE//CHEMISTRY, PHYSICAL//MATERIALS SCIENCE, MULTIDISCIPLINARY | 1554940 |
88 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//CHITOSAN | 80849 |
173 | 2 | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//SOLID DISPERSION//INTERNATIONAL JOURNAL OF PHARMACEUTICS | 21504 |
9837 | 1 | NANOSUSPENSION//ANTISOLVENT PRECIPITATION//DRUG NANOPARTICLES | 1149 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | NANOSUSPENSION | authKW | 5550832 | 26% | 69% | 295 |
2 | ANTISOLVENT PRECIPITATION | authKW | 448797 | 3% | 55% | 30 |
3 | DRUG NANOPARTICLES | authKW | 431176 | 2% | 60% | 26 |
4 | DRUG NANOCRYSTALS | authKW | 430497 | 2% | 83% | 19 |
5 | WET MEDIA MILLING | authKW | 423172 | 2% | 86% | 18 |
6 | HIGH PRESSURE HOMOGENIZATION | authKW | 398000 | 7% | 18% | 81 |
7 | PHARMACEUT BIOPHARMACEUT NUTRICOSMET | address | 376515 | 3% | 44% | 31 |
8 | MEDIA MILLING | authKW | 365696 | 2% | 67% | 20 |
9 | POORLY WATER SOLUBLE DRUG | authKW | 332770 | 6% | 18% | 68 |
10 | SATURATION SOLUBILITY | authKW | 257128 | 1% | 63% | 15 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 17040 | 70% | 0% | 799 |
2 | Chemistry, Medicinal | 2383 | 14% | 0% | 161 |
3 | Materials Science, Biomaterials | 1169 | 6% | 0% | 64 |
4 | Chemistry, Multidisciplinary | 835 | 20% | 0% | 226 |
5 | Nanoscience & Nanotechnology | 735 | 10% | 0% | 110 |
6 | Engineering, Chemical | 266 | 8% | 0% | 89 |
7 | Biophysics | 38 | 3% | 0% | 37 |
8 | Materials Science, Multidisciplinary | 33 | 8% | 0% | 88 |
9 | Medicine, Research & Experimental | 21 | 3% | 0% | 33 |
10 | Chemistry, Physical | 20 | 6% | 0% | 73 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PHARMACEUT BIOPHARMACEUT NUTRICOSMET | 376515 | 3% | 44% | 31 |
2 | SIN CHINA NANO TECHNOL | 165931 | 1% | 55% | 11 |
3 | OTTO H YORK CHEM BIOL PHARMACEUT ENGN | 140424 | 2% | 20% | 26 |
4 | CHEM BIOCHEM PHARMACEUT ENGN | 114282 | 0% | 83% | 5 |
5 | GIPS | 114282 | 0% | 83% | 5 |
6 | DISCOVERY DRUG METAB PHARMACOKINET BIOANALYT | 73139 | 0% | 67% | 4 |
7 | BAXTER PHARMACEUT TECHNOL | 54856 | 0% | 100% | 2 |
8 | BEIJING ENGN NANOMICRO STRUCT DRUGS | 54856 | 0% | 100% | 2 |
9 | CANADA CHAIR LASER MICRO NANOENGN MAT | 54856 | 0% | 100% | 2 |
10 | NCE CPS PROD DEV | 54856 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 89046 | 20% | 1% | 230 |
2 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 19923 | 5% | 1% | 53 |
3 | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 19519 | 5% | 1% | 63 |
4 | AAPS PHARMSCITECH | 12904 | 3% | 2% | 31 |
5 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 9842 | 3% | 1% | 37 |
6 | DRUG DELIVERY AND TRANSLATIONAL RESEARCH | 9683 | 1% | 3% | 11 |
7 | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY | 6721 | 2% | 1% | 19 |
8 | JOURNAL OF PHARMACEUTICAL SCIENCES | 5739 | 4% | 0% | 49 |
9 | INTERNATIONAL JOURNAL OF NANOMEDICINE | 5595 | 2% | 1% | 27 |
10 | COLLOIDS AND SURFACES B-BIOINTERFACES | 5024 | 3% | 1% | 37 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |